Expert Review of Pharmacoeconomics & Outcomes Research
Volume 22, 2022 - Issue 6
Original Research
Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective
Enrique de Alavaa Pathology Unit, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain;b Department of Normal and Pathological Cytology and Histology, School of Medicine, University of Seville, Seville, Spain
https://orcid.org/0000-0001-8400-046XView further author information
https://orcid.org/0000-0001-8400-046XView further author information, María Jesús Parejac Managing Director of the Health Management Area of South Sevilla, Spain;d Coordinator of the Clinical Laboratory Network of Andaluciahttps://orcid.org/0000-0003-2516-7926View further author information
https://orcid.org/0000-0003-2516-7926View further author information, David Carcedoe Hygeia Consulting, Madrid, SpainCorrespondence[email protected]
https://orcid.org/0000-0002-2809-7399View further author information
https://orcid.org/0000-0002-2809-7399View further author information, , & Reyes Bernabé-Carog Institute for Biomedical Research in Seville (IBIS/ SNRC/Seville University), Sevilla, Spainhttps://orcid.org/0000-0003-0312-9195View further author information
https://orcid.org/0000-0003-0312-9195View further author information